Cargando…
What can we learn from study of Alzheimer's disease in patients with Down syndrome for early-onset Alzheimer's disease in the general population?
The clinical and scientific study of dementia in adults with Down syndrome led to the development of the amyloid hypothesis as a fundamental concept in Alzheimer's disease pathogenesis. The journey started with the discovery of the structure and metabolic processing of β-amyloid brain deposits...
Autores principales: | Wallace, Robyn A, Dalton, Arthur J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226275/ https://www.ncbi.nlm.nih.gov/pubmed/21542885 http://dx.doi.org/10.1186/alzrt72 |
Ejemplares similares
-
Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease
por: Dekker, Alain D., et al.
Publicado: (2017) -
Alzheimer’s Disease: What Can We Learn From the Peripheral Olfactory System?
por: Dibattista, Michele, et al.
Publicado: (2020) -
Early and late-onset Alzheimer's disease: What are the differences?
por: Awada, Adnan A.
Publicado: (2015) -
Early-Onset Alzheimer’s Disease: What Is Missing in Research?
por: Ayodele, Temitope, et al.
Publicado: (2021) -
The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
por: Drummond, Eleanor, et al.
Publicado: (2022)